AKEBIA THERAPEUTICS, INC. Debt Securities, Available-for-sale, Amortized Cost
AKEBIA THERAPEUTICS, INC. (AKBA) had Debt Securities, Available-for-sale, Amortized Cost of $0 as of 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2022-03-01
- 2021-09-30: Debt Securities, Available-for-sale, Amortized Cost $0.00.
- 2021-06-30: Debt Securities, Available-for-sale, Amortized Cost $0.00.
- 2021-03-31: Debt Securities, Available-for-sale, Amortized Cost $20.00M.
- 2020-12-31: Debt Securities, Available-for-sale, Amortized Cost $39.98M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $20.00M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $39.98M 10-K · filed 2022-03-01 |
| 2020-09-30 | $99.96M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $49.95M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $245.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $22.72M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $49.53M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $105.33M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $217.26M 10-K · filed 2020-03-12 |
| 2018-09-30 | $228.12M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $239.06M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $248.08M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |